Screening caused rising incidence rates of ductal carcinoma in situ of the breast

被引:62
作者
van Steenbergen, L. N. [1 ]
Voogd, A. C. [2 ]
Roukema, J. A. [3 ]
Louwman, W. J. [1 ]
Duijm, L. E. M. [4 ]
Coebergh, J. W. W. [1 ,5 ]
de Poll-Franse, L. V. van [1 ]
机构
[1] Comprehens Canc Ctr S, Eindhoven Canc Registry, NL-5600 AE Eindhoven, Netherlands
[2] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[3] St Elizabeth Hosp, Dept Surg, NL-5000 LC Tilburg, Netherlands
[4] Catharina Hosp, Dept Radiol, NL-5602 ZA Eindhoven, Netherlands
[5] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands
关键词
DCIS; Trend; Incidence; Screening; CANCER; NETHERLANDS; MAMMOGRAPHY; TRENDS; WOMEN; RISK;
D O I
10.1007/s10549-008-0067-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The purpose of this study was to examine trends in incidence and detection of ductal carcinoma in situ (DCIS) of the breast in southern Netherlands in the period 1984-2006 and assess the effect of mass screening. All patients with primary DCIS registered between 1984 and 2006 in the population-based Eindhoven Cancer Registry were included (n = 1,767). These data were linked to data from the population-based screening programme. The incidence of DCIS of the breast increased from 3/100,000 to almost 34/100,000 person-years in women aged 50-69 years in southern Netherlands since 1984. Mass screening was responsible for this increase. A stable 60% of DCIS was screen-detected. Over 11% of breast cancer patients have DCIS. In conclusion, the incidence of DCIS increased markedly in southern Netherlands with a clear effect of mammography screening since 1992.
引用
收藏
页码:181 / 183
页数:3
相关论文
共 13 条
[1]
In situ breast cancer: Incidence trend and organised screening programmes in Italy [J].
Barchielli, A ;
Federico, M ;
De Lisi, V ;
Bucchi, L ;
Ferretti, S ;
Paci, E ;
Ponti, A ;
Buiatti, E .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (07) :1045-1050
[2]
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[3]
Choi WS, 1996, CANCER EPIDEM BIOMAR, V5, P317
[4]
Ernster VL, 2002, JNCI-J NATL CANCER I, V94, P1546
[5]
Incidence of and treatment for ductal carcinoma in situ of the breast [J].
Ernster, VL ;
Barclay, J ;
Kerlikowske, K ;
Grady, D ;
Henderson, IC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12) :913-918
[6]
Decreased rates of advanced breast cancer due to mammography screening in The Netherlands [J].
Fracheboud, J ;
Otto, SJ ;
van Dijck, JAAM ;
Broeders, MJM ;
Verbeek, ALM ;
de Koning, HJ .
BRITISH JOURNAL OF CANCER, 2004, 91 (05) :861-867
[7]
Trends of in situ carcinoma of the breast in Vaud, Switzerland [J].
Levi, F ;
Te, VC ;
Randimbison, L ;
LaVecchia, C .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (06) :903-906
[8]
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands [J].
Louwman, W. J. ;
Voogd, A. C. ;
van Dijck, J. A. A. M. ;
Nieuwenhuijzen, G. A. P. ;
Ribot, J. ;
Pruijt, J. F. M. ;
Coebergh, J. W. W. .
CANCER CAUSES & CONTROL, 2008, 19 (01) :97-106
[9]
Effect of recall rate on earlier screen detection of breast cancers based on the dutch performance indicators [J].
Otten, JDM ;
Karssemeijer, N ;
Hendriks, JHCL ;
Groenewoud, JH ;
Fracheboud, J ;
Verbeek, ALM ;
de Koning, HJ ;
Holland, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (10) :748-754
[10]
Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? [J].
Soerjomataram, Isabelle ;
Coebergh, Jan Willem ;
Louwman, Marieke W. J. ;
Visser, Otto ;
van Leeuwen, Flora E. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) :5038-5039